This content is only available within our institutional offering.

20 Sep 2016
Interim results expected to highlight post IPO investment

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Interim results expected to highlight post IPO investment
MaxCyte, Inc. (MXCT:LON) | 455 63.7 3.2% | Mkt Cap: 468.2m
- Published:
20 Sep 2016 -
Author:
Dr Julie Simmonds -
Pages:
7 -